Cartesian Therapeutics
RNAC
RNAC
67 hedge funds and large institutions have $60.9M invested in Cartesian Therapeutics in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.61% less ownership
Funds ownership: 24.66% → 23.05% (-1.6%)
8% less capital invested
Capital invested by funds: $66.5M → $60.9M (-$5.57M)
Holders
67
Holding in Top 10
–
Calls
$865K
Puts
$170K
Top Buyers
| 1 | +$455K | |
| 2 | +$259K | |
| 3 | +$256K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$249K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$234K |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$1.82M | |
| 3 | -$515K | |
| 4 |
DFG
Delphi Financial Group
Wilmington,
Delaware
|
-$229K |
| 5 |
Renaissance Technologies
New York
|
-$203K |
